2-Chloromethyl-3,4-Dimethoxypyridine Hydrochloride (Panto Chloro)

2-Chloromethyl-3,4-Dimethoxypyridine Hydrochloride (Panto Chloro) chemical structure

2-Chloromethyl-3,4-Dimethoxypyridine Hydrochloride (Panto Chloro)

CAS Number:72830-09-2
End Use:Pantoprazole Sodium
COA:Available
DMF:Available
Description
Name of Product: 2-Chloromethyl-3,4-Dimethoxypyridine Hydrochloride (Panto Chloro)
Form: Powder
End Use: Pantoprazole Sodium
CAS Number: 72830-09-2

Holiness Pharmaceutical is a trusted and leading pharmaceutical intermediate exporter, supplier and manufacturer of 2-Chloromethyl-3,4-Dimethoxypyridine Hydrochloride (Panto Chloro), a key pyridine-based advanced intermediate used in the synthesis of Pantoprazole Sodium API, a proton pump inhibitor for acid-related disorders. We supply high-purity intermediates to pharmaceutical manufacturers across 40+ international markets, supporting regulated and semi-regulated API production.

Globally, Holiness Pharmaceutical is recognized among reliable Pantoprazole intermediate manufacturers, offering consistent chemical purity, controlled halomethyl functionality, and stable salt formation essential for downstream coupling and final API crystallization. Our expertise in heterocyclic pyridine chemistry and PPI intermediates positions us as a dependable pharmaceutical intermediate exporter from India.

Our advanced intermediate manufacturing facilities operate in strict compliance with international quality standards including:
DCGI, WHO-GMP aligned, and cGMP guidelines,
ensuring validated synthetic routes, batch-to-batch consistency, traceability, and comprehensive quality documentation.

We export 2-Chloromethyl-3,4-Dimethoxypyridine Hydrochloride and other high-value pharmaceutical intermediates from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting API manufacturers focused on gastrointestinal therapies.

Holiness Pharmaceutical Ltd. is a fully integrated organization engaged in the complete lifecycle of intermediates — including route scouting, heterocyclic synthesis, process optimization, commercial-scale manufacturing, and global supply of advanced intermediates for regulated APIs.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.

Send Inquiry